Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARS1 | P56192 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.42 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | RXRG | P48443 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3833333 | 0.88 | CYP1A2 (0.50) | MAPTSLC16A3SLC16A1PTGDR2KDM4E | |
| SCHEMBL11255264 | 0.86 | CYP1A2 (0.50) | POLBMDM2RXRARXRBRXRG | |
| SCHEMBL1195159 | 0.77 | CYP2C9 (0.62) | POLBPTGDR2P2RX7 | |
| SCHEMBL4158179 | 0.77 | MEN1 (0.50) | GAAKDM4EMYCWDR5 | |
| SCHEMBL11242627 | 0.76 | CYP1A2 (0.52) | LMNAGAAMAPTPTGDR2KDM4E | |
| SCHEMBL11252577 | 0.76 | CYP1A2 (0.52) | LMNAMAPTKDM4EP2RX7 | |
| SCHEMBL11253889 | 0.76 | P2RX7 (0.59) | PKMPTGDR2P2RX7 | |
| SCHEMBL3835898 | 0.75 | PTGDR2 (0.47) | POLBGAAMAPTPTGDR2KDM4E | |
| SCHEMBL11254556 | 0.73 | PTGDR2 (0.47) | MDM2RXRARXRBRXRGPTGDR2 | |
| SCHEMBL11247967 | 0.72 | CYP2C9 (0.56) | LMNAPOLBGAAMAPTPTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2106213-B1 | SUBSTITUTED 1-(3-PYRIDINYL)PYRAZOL-4-YL-ACETIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDE AND PLANT GROWTH REGULATORS | BAYER IP GMBH (DE) | 2015-02-11 | — | — | EP | disclosed |
| US-8252723-B2 | Substituted 1-(3-pyridinyl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators | BAYER CROPSCIENCE AG (DE) | 2012-08-28 | — | — | US | disclosed |
| US-20090036310-A1 | Substituted 1-(3-pyridinyl)pyrazol-4-ylacetic Acids, Processes for Their Preparation and Their Use as Herbicides and Plant Growth Regulators | BAYER CORPSCIENCE GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1938686-A1 | Substituted 1-(3-pyridinyl)pyrazol-4-yl-acetic acids, process for their preparation and their use as herbicide and plant growth regulator. | Bayer CropScience AG (DE) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036310-A1 | Substituted 1-(3-pyridinyl)pyrazol-4-ylacetic Acids, Processes for Their Preparation and Their Use as Herbicides and Plant Growth Regulators | DDT, DDC, HPD | MARS1 2210/4885LMNA 4112/4885POLB 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.